Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Public ClinicalTrials.gov record NCT04907643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Study identification
- NCT ID
- NCT04907643
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Cedars-Sinai Medical Center
- Other
- Enrollment
- 360 participants
Conditions and interventions
Conditions
- Ampullary Cancer
- Anal Cancer
- Anal Cancer Metastatic
- Anal Cancer Recurrent
- Anal Cancer Stage III
- Anal Cancer Stage IV
- Anal Cancer, Stage IIIA
- Anal Cancer, Stage IIIB
- Appendix Cancer
- Bile Duct Cancer
- Bile Duct Cancer Recurrent
- Bile Duct Cancer Stage I
- Bile Duct Cancer Stage II
- Bile Duct Cancer Stage III
- Bile Duct Cancer Stage IV
- Bile Duct Cancer Stage IVA
- Bile Duct Cancer Stage IVB
- Biliary Tract Cancer
- Cancer Pain
- Cancer of Gastrointestinal Tract
- Carcinoid Tumor
- Carcinoid Tumor of Cecum
- Carcinoid Tumor of Colon
- Carcinoid Tumor of GI System
- Carcinoid Tumor of Ileum
- Carcinoid Tumor of Large Intestine
- Carcinoid Tumor of Liver
- Carcinoid Tumor of Pancreas
- Carcinoid Tumor of Rectum
- Carcinoid Tumor of the Small Bowel
- Carcinoid Tumor of the Stomach
- Colon Cancer
- Colon Cancer Stage III
- Colon Cancer Stage IV
- Esophagus Cancer
- Esophagus Cancer, Recurrent
- Esophagus Cancer, Stage I
- Esophagus Cancer, Stage II
- Esophagus Cancer, Stage III
- Esophagus Cancer, Stage IV
- Gallbladder Cancer
- Gallbladder Cancer Stage I
- Gallbladder Cancer Stage II
- Gallbladder Cancer Stage III
- Gallbladder Cancer Stage IV
- Gastric (Stomach) Cancer
- Gastrointestinal Cancer Metastatic
- Gastrointestinal Cancers - Anus
- Gastrointestinal Cancers - Colorectal
- Gastrointestinal Cancers - Liver
- Gastrointestinal Cancers - Small Intestine
- Gastrointestinal Cancers - Stomach
- Gastrointestinal Neoplasms
- Large Intestine Cancer
- Liver Cancer
- Liver Cancer Stage IIIa
- Liver Cancer Stage IIIb
- Liver Cancer Stage IIIc
- Liver Cancer Stage IV
- Neuroendocrine Tumor
- Pancreas Cancer
- Pancreas Cancer, Metastatic
- Pancreas Cancer, Recurrent
- Pancreas Cancer, Stage III
- Pancreas Cancer, Stage IV
- Peritoneal Cancer
- Peritoneum Cancer
- Rectal Cancer
- Rectum Cancer
- Rectum Cancer, Recurrent
- Small Intestine Cancer
- Small Intestine Cancer Stage III
- Small Intestine Cancer Stage IV
- Small Intestine Cancer, Recurrent
- Stomach Cancer
- Stomach Cancer Recurrent
- Stomach Cancer Stage III
- Stomach Cancer Stage IV
- Visceral Pain
Interventions
- PICO G2 4k Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 4, 2021
- Primary completion
- Dec 31, 2026
- Completion
- Mar 15, 2027
- Last update posted
- Feb 19, 2026
2021 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04907643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 19, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04907643 live on ClinicalTrials.gov.